Quantile-based fecal hemoglobin concentration for assessing colorectal neoplasms with 1,263,717 Taiwanese screenees.
Szu-Min PengHan-Mo ChiuHsiao-Hsuan JenChen-Yang HsuSam Li-Sheng ChenSherry Yueh-Hsia ChiuAmy Ming-Fang YenJean Ching-Yuan FannYi-Chia LeeTony Hsiu-Hsi ChenPublished in: BMC medical informatics and decision making (2019)
Covariate-adjusted risk stratification for multistage outcomes of colorectal neoplasia were provided by using the quantiles of fecal hemoglobin concentration, yielding the estimated life-time risks of 25th to 75th quantitles, ranging from 0.5 to 44% for colorectal cancer, 0.2 to 46% for non-advanced adenoma, and 0.1 to 20% for advanced adenoma.